Mesa Laboratories Inc (MLAB) Annual Income Statement (USD)
MLAB Quarterly Financials (USD)
Frequently Asked Questions About Mesa Laboratories Inc (MLAB) Stock
Mesa Laboratories Inc's (MLAB) last reported annual revenue was USD 216.19 Million.
Mesa Laboratories Inc's (MLAB) annual revenue growth rate based on the revenue reported in the past 5 years is : 15.95%
Mesa Laboratories Inc's(MLAB) is not profitable as of its last reported annual financials.
The net profit margin for Mesa Laboratories Inc's(MLAB) from its laster reported year is -117.60%
The return on equity (ROE) for Mesa Laboratories Inc's(MLAB) from its last reported annual financials is : -89.38%
The return on assets (ROA) for Mesa Laboratories Inc's(MLAB) from its last reported annual financials is : 2.18%
The return on invested capital (ROIC) for Mesa Laboratories Inc's(MLAB) from its last reported annual financials is : -53.12%
The Debt to Equity ratio for Mesa Laboratories Inc's(MLAB) from its last reported annual financials is : 152.48%
The dividend yield for Mesa Laboratories Inc's(MLAB) from its laster reported year is 0.54%
Mesa Laboratories Inc's(MLAB) has negative cash flow as of its last reported annual financials.
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Low volatility
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior Revenue Growth
This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.
Superior Dividend Growth
This stock has shown top quartile dividend growth in the previous 5 years compared to its sector
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Below median total returns
The company has under performed its peers on annual average total returns in the past 5 years.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Highly leveraged
The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for MLAB !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
